Secukinumab Antibody, CAS [[1229022-83-6]], Unconjugated

Produktübersicht

• Artikelname: Secukinumab Antibody, CAS [[1229022-83-6]], Unconjugated
• Artikelnummer: BYT-ORB1297791
• Hersteller Artikelnummer: orb1297791
• Alternativnummer: BYT-ORB1297791-1, BYT-ORB1297791-10, BYT-ORB1297791-25, BYT-ORB1297791-5, BYT-ORB1297791-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Konjugation: Unconjugated
• Alternative Synonym: ILReceptor, IL Receptor, IL-17A, Secukinumab

Produktbeschreibung

Secukinumab is a fully human monoclonal antibody that selectively neutralizes interleukin-17A (IL-17A). It was the first IL-17A antagonist approved by the FDA for moderate-to-severe plaque psoriasis. This reagent is widely used in immunology and dermatology research, including in vitro cytokine blockade studies and in vivo models of autoimmune inflammation.

Produkteigenschaften

• Konzentration: 8.2 mg/mL
• Molekulargewicht: 147.93 kDa
• Reinheit: 99.10% (May vary between batches)
• CAS Nummer: [1229022-83-6]
• Target-Kategorie: Interleukin,IL Receptor